AU2011227226B2 - Method for using a Bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions - Google Patents

Method for using a Bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions Download PDF

Info

Publication number
AU2011227226B2
AU2011227226B2 AU2011227226A AU2011227226A AU2011227226B2 AU 2011227226 B2 AU2011227226 B2 AU 2011227226B2 AU 2011227226 A AU2011227226 A AU 2011227226A AU 2011227226 A AU2011227226 A AU 2011227226A AU 2011227226 B2 AU2011227226 B2 AU 2011227226B2
Authority
AU
Australia
Prior art keywords
bacillus subtilis
composition
subtilis qst713
qst713
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011227226A
Other languages
English (en)
Other versions
AU2011227226A1 (en
Inventor
Desmond Rito Jimenez
Joseph Earl Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience LP
Original Assignee
Bayer CropScience LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience LP filed Critical Bayer CropScience LP
Publication of AU2011227226A1 publication Critical patent/AU2011227226A1/en
Assigned to BAYER CROPSCIENCES LP reassignment BAYER CROPSCIENCES LP Request for Assignment Assignors: AGRAQUEST, INC.
Application granted granted Critical
Publication of AU2011227226B2 publication Critical patent/AU2011227226B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2011227226A 2010-03-17 2011-03-17 Method for using a Bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions Active AU2011227226B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31499710P 2010-03-17 2010-03-17
US61/314,997 2010-03-17
PCT/US2011/028755 WO2011116155A1 (en) 2010-03-17 2011-03-17 Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions

Publications (2)

Publication Number Publication Date
AU2011227226A1 AU2011227226A1 (en) 2012-11-08
AU2011227226B2 true AU2011227226B2 (en) 2017-02-16

Family

ID=44072771

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011227226A Active AU2011227226B2 (en) 2010-03-17 2011-03-17 Method for using a Bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions

Country Status (10)

Country Link
US (1) US9457054B2 (https=)
EP (1) EP2547348B1 (https=)
JP (1) JP5830084B2 (https=)
AU (1) AU2011227226B2 (https=)
DK (1) DK2547348T3 (https=)
ES (1) ES2550059T3 (https=)
MY (1) MY161197A (https=)
NZ (1) NZ603065A (https=)
PL (1) PL2547348T3 (https=)
WO (1) WO2011116155A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021032975A1 (en) * 2019-08-20 2021-02-25 Sporegen Limitd Formulations for prevention or reduction of c. difficile infections

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009293213C1 (en) * 2008-09-17 2015-04-30 Bayer Cropscience Lp Method for using a Bacillus subtilis strain to enhance animal health
EP2547348B1 (en) 2010-03-17 2015-05-20 Bayer Cropscience LP Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
MX347345B (es) 2011-05-24 2017-04-21 Bayer Cropscience Lp Combinaciones sinergicasde fungicidas polienicos y peptidos no ribosomales y metodos de uso relacionados.
CA2865219A1 (en) * 2012-02-21 2013-08-29 Dupont Nutrition Biosciences Aps Composition
FR3007654B1 (fr) * 2013-06-27 2015-07-10 Lesaffre & Cie Composition de solute de rehydratation orale contenant des probiotiques
FR3007655B1 (fr) * 2013-06-28 2016-12-23 Lesaffre & Cie Souche bacillus subtilis pour le traitement et/ou la prevention de maladies inflammatoires chroniques
JP6440463B2 (ja) * 2013-11-15 2018-12-19 プリマハム株式会社 抗菌作用を有するバチルス・メチロトロフィカス
JP6671950B2 (ja) * 2015-12-18 2020-03-25 アサヒカルピスウェルネス株式会社 機能性胃腸症改善剤
JP7104078B2 (ja) * 2017-06-30 2022-07-20 エボニック オペレーションズ ゲーエムベーハー プロバイオティクス活性がある枯草菌株
US12194142B2 (en) 2017-09-25 2025-01-14 Deerland Enzymes, Inc. Bacillus subtilis containing composition for treatment of gastrointestinal irregularity
WO2019147799A1 (en) 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
BE1027162B1 (nl) * 2019-03-29 2020-11-05 My Res Comm V Bacillus coagulans en Bacillus subtilis voor de preventie en behandeling van functionele gastro-intestinale stoornissen
US11160838B2 (en) 2019-08-09 2021-11-02 Deerland Enzymes, Inc. Antifungal and antimicrobial uses of Bacillus subtilis containing compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060051A (en) * 1997-05-09 2000-05-09 Agraquest, Inc. Strain of bacillus for controlling plant diseases and corn rootworm
US6103228A (en) * 1997-05-09 2000-08-15 Agraquest, Inc. Compositions and methods for controlling plant pests
WO2010033714A1 (en) * 2008-09-17 2010-03-25 Agraquest, Inc. Method for using a bacillus subtilis strain to enhance animal health

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62232343A (ja) 1986-04-01 1987-10-12 Kyodo Shiryo Kk 幼豚用配合飼料
JPS63209580A (ja) 1987-02-25 1988-08-31 Karupisu Shokuhin Kogyo Kk バチルス・ズブチリスｃ−３１０２
KR930001383B1 (ko) * 1990-10-31 1993-02-27 재단법인 한국화학연구소 신규의 바실러스 서브틸리스 아종 및 이로부터 생산되는 항진균 물질 krf-001 복합체의 용도
US5785990A (en) 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
JP2979294B2 (ja) 1996-10-02 1999-11-15 カルピス株式会社 鳥類卵殻強度増強剤
US6015553A (en) 1997-08-22 2000-01-18 Agraquest, Inc. Bacillus subtilis strain for controlling insect and nematode pests
JP3260111B2 (ja) 1997-10-09 2002-02-25 伊藤忠飼料株式会社 鳥類の給餌中止時の体重減少抑制方法及び腸内有害細菌減少方法
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
JP2000166583A (ja) * 1998-10-02 2000-06-20 Shin Nihonsha:Kk 枯草菌等が産生する無機物及びその酸塩と副産物及びその誘導体
GB0124580D0 (en) 2001-10-12 2001-12-05 Univ Reading New composition
GB0130789D0 (en) 2001-12-21 2002-02-06 King S College London Application of spores
AR040927A1 (es) 2002-04-10 2005-04-27 Cooperativas Argentinas Cooper Alimento para la crianza de vacunos neonatos y procedimiento de utilizacion.
AT413191B (de) 2002-10-11 2005-12-15 Erber Ag Futtermittel- und/oder trinkwasserzusatz für nutztiere
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
EP1472933A1 (en) 2003-05-01 2004-11-03 Chr. Hansen A/S Improving health and/or nutritional status of an aquatic animal by aid of Bacillus licheniformis
US20070065540A1 (en) 2003-07-24 2007-03-22 Jones Alison M Enhanced steep-water
RU2266747C1 (ru) 2004-03-22 2005-12-27 Кубанский государственный аграрный университет Пробиотическая композиция для животных и птицы
JP2007054041A (ja) 2005-07-29 2007-03-08 Yodorinon Kenkyusho:Kk 養鶏飼料並びに卵
US20080057047A1 (en) 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
US7754469B2 (en) * 2005-11-30 2010-07-13 Agtech Products, Inc Microorganisms and methods for treating poultry
JP4968816B2 (ja) * 2006-03-08 2012-07-04 日本曹達株式会社 バチルス属細菌の芽胞形成方法
WO2007150052A1 (en) * 2006-06-23 2007-12-27 Equine Research Associates, Ltd Animal nutritional supplement and method
NZ600929A (en) * 2007-09-20 2014-02-28 Basf Se Combinations comprising a fungicidal strain and an active compound
US8227235B2 (en) 2008-12-10 2012-07-24 Alpharma, Llc Compositions and methods for controlling diseases in animals
EP2547348B1 (en) 2010-03-17 2015-05-20 Bayer Cropscience LP Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060051A (en) * 1997-05-09 2000-05-09 Agraquest, Inc. Strain of bacillus for controlling plant diseases and corn rootworm
US6103228A (en) * 1997-05-09 2000-08-15 Agraquest, Inc. Compositions and methods for controlling plant pests
WO2010033714A1 (en) * 2008-09-17 2010-03-25 Agraquest, Inc. Method for using a bacillus subtilis strain to enhance animal health

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021032975A1 (en) * 2019-08-20 2021-02-25 Sporegen Limitd Formulations for prevention or reduction of c. difficile infections

Also Published As

Publication number Publication date
US9457054B2 (en) 2016-10-04
JP2013522315A (ja) 2013-06-13
AU2011227226A1 (en) 2012-11-08
NZ603065A (en) 2014-12-24
WO2011116155A1 (en) 2011-09-22
ES2550059T3 (es) 2015-11-04
EP2547348A1 (en) 2013-01-23
PL2547348T3 (pl) 2015-11-30
JP5830084B2 (ja) 2015-12-09
US20120328571A1 (en) 2012-12-27
DK2547348T3 (da) 2015-08-24
MY161197A (en) 2017-04-14
EP2547348B1 (en) 2015-05-20

Similar Documents

Publication Publication Date Title
AU2011227226B2 (en) Method for using a Bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
JP4623896B2 (ja) ヒトおよび動物に使用される細菌株、加工された植物抽出物およびプロバイオティック組成物
JP5718916B2 (ja) 新規なラクトバチルス・プランタラム及びこれを含む組成物
KR101772870B1 (ko) 프로바이오틱 활성을 갖는 신규 락토바실러스 플란타럼 및 이의 용도
US20080102061A1 (en) Use hydrolyzed medium containing microorganisms medicinally
JP2007518693A (ja) 安定な液体プロバイオティクス組成物、その調製および適用
JP2002523372A (ja) 共生乳酸産生細菌およびその使用
CN104789511B (zh) 一株具有广谱抑菌特性的植物乳杆菌ab-2及其应用
KR102391832B1 (ko) 클로스트리디오이데스 디피실 억제용 유산균 복합 균주 및 이를 포함하는 장염증 예방, 치료 또는 개선용 조성물
CN111011856A (zh) 用于缓解胃病的组合物、其制备方法及用于缓解胃病的食品
AU3472693A (en) Probiotic for control of salmonella
KR20180011490A (ko) 프로바이오틱 활성을 갖는 신규 락토바실러스 퍼멘텀 및 이의 용도
KR102452957B1 (ko) 프로바이오틱스 균주를 유효성분으로 포함하는 클로스트리디오이데스 디피실레 감염을 예방 또는 치료하기 위한 조성물
KR20240037257A (ko) 위장관 장애의 치료에서의 사용을 위한 생리학적으로 허용되는 효모 조성물
KR101000364B1 (ko) 생존율 증강용 이중 코팅 방법
JPH06166626A (ja) 生菌粉末
KR101772875B1 (ko) 프로바이오틱 활성을 갖는 신규 락토바실러스 플란타럼 및 이의 용도
KR102617297B1 (ko) 클로스트리디움 디피실리 감염의 치료 또는 예방용 조성물
JP2006180836A (ja) 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物
KR101797139B1 (ko) 신규한 락토바실러스 갈리나룸 균주 및 이의 용도
KR100483369B1 (ko) 파일로리 및 리스테리아 모노사이토진의 생육을 억제하는 항균활성물질을 생산하는 페디오코커스 펜토사세우스ｃｂｔ-8로 명명되는 유산균주, 이를 이용한 항균특성을 갖는 항균물질 제조 방법 및 그 제조된 항균물질 기능성식품 및 의약품에 이용하는 방법
KR20220008218A (ko) 염증성 장질환 예방 또는 치료용 조성물
KR100855022B1 (ko) 락토바실러스 파라플란타룸 ｋｎｕｃ２５를 포함하는헬리코박터 파이로리 생육 억제용 조성물
KR101772872B1 (ko) 프로바이오틱 활성을 갖는 신규 락토바실러스 플란타럼 및 이의 용도
KR102851958B1 (ko) 신규 바실러스 벨레젠시스 균주 및 이의 용도

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: BAYER CROPSCIENCES LP

Free format text: FORMER APPLICANT(S): AGRAQUEST, INC.

TH Corrigenda

Free format text: IN VOL 31 , NO 4 , PAGE(S) 475 UNDER THE HEADING ASSIGNMENTS BEFORE GRANT, SECTION 113 - 2011 UNDER THE NAME BAYER CROPSCIENCES LP, APPLICATION NO. 2011227226, UNDER INID (71) CORRECT APPLICANT NAME TO READ BAYER CROPSCIENCE LP

FGA Letters patent sealed or granted (standard patent)